Drug repositioning for Alzheimer's disease, Nature Reviews Drug Discovery, vol.32, issue.11, pp.833-846, 2012. ,
DOI : 10.1038/nrd3869
The diagnosis of mild cognitive impairment due to Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer???s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.270-279, 2011. ,
DOI : 10.1016/j.jalz.2011.03.008
Classification and basic pathology of Alzheimer disease, Acta Neuropathologica, vol.14, issue.2, pp.5-36, 2009. ,
DOI : 10.1007/s00401-009-0532-1
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, New England Journal of Medicine, vol.367, issue.9, pp.795-804, 2012. ,
DOI : 10.1056/NEJMoa1202753
Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders, Annals of Neurology, vol.270, issue.suppl 1, pp.532-540, 2011. ,
DOI : 10.1002/ana.22615
Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system, Neuron, vol.14, pp.671-680, 1995. ,
Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis ,
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome, Neurobiol Aging, vol.25, pp.1263-1272, 2004. ,
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am J Pathol, vol.157, pp.277-286, 2000. ,
Endocytic disturbances distinguish among subtypes of alzheimer's disease and related disorders, Annals of Neurology, vol.53, issue.5, pp.661-665, 2001. ,
DOI : 10.1002/ana.1254
Plasma ?? amyloid and the risk of Alzheimer's disease in Down syndrome, Neurobiology of Aging, vol.33, issue.9, pp.1988-1994, 2012. ,
DOI : 10.1016/j.neurobiolaging.2011.08.007
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology, The American Journal of Pathology, vol.173, issue.2, pp.370-384, 2008. ,
DOI : 10.2353/ajpath.2008.071053
Trisomy for Synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes, Human Molecular Genetics, vol.21, issue.14, pp.3156-3172, 2012. ,
DOI : 10.1093/hmg/dds142
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nature Genetics, vol.12, issue.10, pp.1094-1099, 2009. ,
DOI : 10.1038/ng.439
Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer???s Disease, NeuroMolecular Medicine, vol.7, issue.1, pp.150-160, 2014. ,
DOI : 10.1007/s12017-013-8269-3
Utilisation des biomarqueurs du LCR dans le diagnostic de la maladie d???Alzheimer en pratique clinique, Revue Neurologique, vol.167, issue.6-7, pp.474-484, 2011. ,
DOI : 10.1016/j.neurol.2010.10.007
Similar beta-amyloid burden in posterior cortical atrophy and Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.4, pp.2036-2043, 2011. ,
DOI : 10.1016/j.jalz.2011.05.919
Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.3, pp.240-246, 2011. ,
DOI : 10.1136/jnnp.2010.207183
Extraction of spots in biological images using multiscale products, Pattern Recognition, vol.35, issue.9, pp.1989-1996, 2002. ,
DOI : 10.1016/S0031-3203(01)00127-3
Icy: an open bioimage informatics platform for extended reproducible research, Nature Methods, vol.9, issue.7, pp.690-696, 2012. ,
DOI : 10.1038/nmeth.2075
Imaging ??-amyloid burden in aging and dementia, Neurology, vol.68, issue.20, pp.1718-1725, 2007. ,
DOI : 10.1212/01.wnl.0000261919.22630.ea
Developing novel blood-based biomarkers for Alzheimer's disease, Alzheimer's & Dementia, vol.10, issue.1, pp.109-114, 2014. ,
DOI : 10.1016/j.jalz.2013.10.007
Alzheimer???s Disease Risk Genes and Mechanisms of Disease Pathogenesis, Biological Psychiatry, vol.77, issue.1, pp.43-51, 2015. ,
DOI : 10.1016/j.biopsych.2014.05.006
Alzheimer's-related endosome dysfunction in Down syndrome is A??-independent but requires APP and is reversed by BACE-1 inhibition, Proceedings of the National Academy of Sciences, vol.107, issue.4, pp.1630-1635, 2009. ,
DOI : 10.1073/pnas.0908953107
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer???s disease patients and controls, Acta Neuropathologica, vol.70, issue.Suppl, pp.633-643, 2014. ,
DOI : 10.1007/s00401-014-1266-2
Plasma concentrations of the amyloid-beta peptides in young volunteers: the influence of the APOE genotype, J Alzheimers Dis, vol.40, pp.1055-1060, 2014. ,
Association of plasma and cortical amyloid beta is modulated by APOE ??4 status, Alzheimer's & Dementia, vol.10, issue.1, pp.9-18, 2014. ,
DOI : 10.1016/j.jalz.2013.01.007
Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy, Acta Neuropathologica, vol.10, issue.2, pp.111-124, 2009. ,
DOI : 10.1007/s00401-008-0481-0
An increased neutrophil???lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation, Journal of Neuroimmunology, vol.273, issue.1-2, pp.65-71, 2014. ,
DOI : 10.1016/j.jneuroim.2014.05.005
Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1801, issue.8, pp.839-845, 2010. ,
DOI : 10.1016/j.bbalip.2010.03.010
Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol, Biochim Biophys Acta, vol.1801, pp.846-852, 2010. ,
Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis, The FASEB Journal, vol.25, issue.4, pp.1295-1305, 2011. ,
DOI : 10.1096/fj.10-168633
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.101, issue.7, pp.2070-2075, 2004. ,
DOI : 10.1073/pnas.0305799101
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients, Acta Neuropathologica, vol.29, issue.3, pp.133-144, 2012. ,
DOI : 10.1007/s00401-012-1041-1
URL : https://hal.archives-ouvertes.fr/hal-00772814
Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry, The Journal of Lipid Research, vol.51, issue.3, pp.598-605, 2010. ,
DOI : 10.1194/jlr.M001859
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease, BMC Med, vol.7, p.66, 2009. ,
Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients, Lipids in Health and Disease, vol.11, issue.1, p.39, 2012. ,
DOI : 10.1016/S0896-6273(03)00434-3